Aducanumab and the FDA — where are we now?

Title
Aducanumab and the FDA — where are we now?
Authors
Keywords
-
Journal
Nature Reviews Neurology
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-01-13
DOI
10.1038/s41582-020-00454-9

Ask authors/readers for more resources

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started